Literature DB >> 27525708

Calcium Homeostasis During Attack and Remission in Patients With Idiopathic Benign Paroxysmal Positional Vertigo.

Serif Samil Kahraman1, Oguzhan Ozcan, Cengiz Arli, Ihsan Ustun, Rana Erduran, Ertap Akoglu, Cumali Gokce.   

Abstract

OBJECTIVE: To evaluate changes in calcium metabolism in patients with idiopathic benign paroxysmal positional vertigo (BPPV) on initial presentation and at the follow-up visit. SUBJECTS AND METHODS: The study comprised a total of 31 patients aged greater than 18 years who presented at the otorhinolaryngology outpatient clinic of our hospital, newly diagnosed as idiopathic BPPV based on the history compatible with BPPV and positive provocative maneuver (either Dix-Hallpike or Roll test). The first blood sample was obtained on the day of initial presentation when the patient was found to have active unilateral BPPV. After 6 months, a blood sample was again drawn in accordance with the procedure. Blood samples were analyzed for data on 25-hydroxyvitamin D (25(OH)-D), total calcium, parathormone and ionized calcium on initial presentation, and at the follow-up visit.
RESULTS: The patients comprised 20 (64.5%) women and 11 (35.5%) men with a mean age of 49.78 years (range, 23-75 years). During an attack a higher prevalence of decreased serum Vitamin D is less than 20 ng/ml, was determined (93.5% versus 38.7%). There were statistical differences between the Vitamin D values, parathormone, and corrected by pH ionized calcium in both periods (p < 0.05).
CONCLUSION: A statistically significant association was determined between Vitamin D and calcium metabolism in patients with idiopathic BPPV. It can be considered that Vitamin D deficiency and decreased ionized Ca level may be a risk for BPPV, not only in patients with osteoporosis but also in all patients. Very low levels of 25(OH)-D seem to be associated with recurrence of BPPV. The recurrences might possibly be prevented with supplementary Vitamin D especially in those with recurrent idiopathic BPPV but further studies would be necessary to determine this.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27525708     DOI: 10.1097/MAO.0000000000001167

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  11 in total

1.  Association between bone mineral density and benign paroxysmal positional vertigo: a meta-analysis.

Authors:  Ling-Ling He; Xin-Yi Li; Miao-Miao Hou; Xiao-Qiong Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-04-27       Impact factor: 2.503

Review 2.  Clinical significance of cervical and ocular vestibular evoked myogenic potentials in benign paroxysmal positional vertigo: a meta-analysis.

Authors:  Ryohei Oya; Takao Imai; Yukinori Takenaka; Takashi Sato; Kazuo Oshima; Yumi Ohta; Hidenori Inohara
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-11       Impact factor: 2.503

3.  A Relationship Between Blood Levels of Otolin-1 and Vitamin D.

Authors:  Kourosh Parham; George A Kuchel; Janet E McElhaney; Laura Haynes
Journal:  Otol Neurotol       Date:  2018-04       Impact factor: 2.311

4.  Dizziness handicap and clinical characteristics of posterior and lateral canal BPPV.

Authors:  Camilla Martens; Frederik Kragerud Goplen; Torbjørn Aasen; Karl Fredrik Nordfalk; Stein Helge Glad Nordahl
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-14       Impact factor: 2.503

Review 5.  Prevention of recurrent benign paroxysmal positional vertigo with vitamin D supplementation: a meta-analysis.

Authors:  Seong-Hae Jeong; Sun-Uk Lee; Ji-Soo Kim
Journal:  J Neurol       Date:  2020-08-07       Impact factor: 4.849

6.  The Relationship Between Benign Paroxysmal Positional Vertigo and Vitamin D.

Authors:  Ali Seyed Resuli; Ahmet Bedir; Abdülkadir Özgür
Journal:  Cureus       Date:  2022-06-18

7.  Hormones and Vestibular Disorders: The Quest for Biomarkers.

Authors:  Rhizlane El Khiati; Brahim Tighilet; Stephane Besnard; Christian Chabbert
Journal:  Brain Sci       Date:  2022-05-02

Review 8.  Benign paroxysmal positional vertigo in the elderly: current insights.

Authors:  D G Balatsouras; G Koukoutsis; A Fassolis; A Moukos; A Apris
Journal:  Clin Interv Aging       Date:  2018-11-05       Impact factor: 4.458

9.  Analysis of effect of 1α-hydroxyvitamin D3 on benign paroxysmal positional vertigo and risk factors.

Authors:  Xiang Gu; Feilin Dong; Jianhua Gu
Journal:  Exp Ther Med       Date:  2018-01-04       Impact factor: 2.447

10.  Review of the pathology underlying benign paroxysmal positional vertigo.

Authors:  Sertac Yetiser
Journal:  J Int Med Res       Date:  2019-12-29       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.